Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Creating reasonable antibiograms for antibiotic stewardship programs in nursing homes: Analysis of 260 facilities in a large geographic region, 2016-2017.

Fridkin SK, Pack J, Licitra G, Zheng Z, Watkins R, Price S, Camp M, Moore R.

Infect Control Hosp Epidemiol. 2019 Aug;40(8):839-846. doi: 10.1017/ice.2019.112. Epub 2019 May 28.

PMID:
31133088
2.

Factors affecting the geographic variability of antibiotic-resistant healthcare-associated infections in the United States using the CDC Antibiotic Resistance Patient Safety Atlas.

Kubes JN, Fridkin SK.

Infect Control Hosp Epidemiol. 2019 May;40(5):597-599. doi: 10.1017/ice.2019.64. Epub 2019 Apr 12.

PMID:
30975229
3.

Evaluating movement of patients with Carbapenem-Resistant Enterobacteriaceae infections in the Greater Atlanta Metropolitan Area using social network analysis.

Bower CW, Fridkin DW, Wolford HM, Slayton RB, Kubes JN, Jacob JT, Ray SM, Fridkin SK.

Clin Infect Dis. 2019 Feb 27. pii: ciz154. doi: 10.1093/cid/ciz154. [Epub ahead of print]

PMID:
30809636
4.

Preventing hospital-acquired Legionnaires' disease: A snapshot of clinical practices and water management approaches in US acute-care hospitals.

Ehret KM, Chamberlain AT, Berkelman RL, Fridkin SK.

Infect Control Hosp Epidemiol. 2018 Dec;39(12):1470-1472. doi: 10.1017/ice.2018.240. Epub 2018 Oct 8.

PMID:
30293535
5.

The Fog May be Lifting Around Antibiotic Use Metrics and Interfacility Comparison.

Fridkin SK.

Clin Infect Dis. 2018 Nov 13;67(11):1686-1687. doi: 10.1093/cid/ciy359. No abstract available.

PMID:
29688288
6.

In Data We Trust? Comparison of Electronic Versus Manual Abstraction of Antimicrobial Prescribing Quality Metrics for Hospitalized Veterans With Pneumonia.

Jones BE, Haroldsen C, Madaras-Kelly K, Goetz MB, Ying J, Sauer B, Jones MM, Leecaster M, Greene T, Fridkin SK, Neuhauser MM, Samore MH.

Med Care. 2018 Jul;56(7):626-633. doi: 10.1097/MLR.0000000000000916.

7.

Zika Virus Infection in Patient with No Known Risk Factors, Utah, USA, 2016.

Krow-Lucal ER, Novosad SA, Dunn AC, Brent CR, Savage HM, Faraji A, Peterson D, Dibbs A, Vietor B, Christensen K, Laven JJ, Godsey MS Jr, Christensen B, Beyer B, Cortese MM, Johnson NC, Panella AJ, Biggerstaff BJ, Rubin M, Fridkin SK, Staples JE, Nakashima AK.

Emerg Infect Dis. 2017 Aug;23(8):1260-1267. doi: 10.3201/eid2308.170479.

8.

Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012.

Baggs J, Fridkin SK, Pollack LA, Srinivasan A, Jernigan JA.

JAMA Intern Med. 2016 Nov 1;176(11):1639-1648. doi: 10.1001/jamainternmed.2016.5651.

PMID:
27653796
9.

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

Weiner LM, Fridkin SK, Aponte-Torres Z, Avery L, Coffin N, Dudeck MA, Edwards JR, Jernigan JA, Konnor R, Soe MM, Peterson K, Clifford McDonald L.

Am J Transplant. 2016 Jul;16(7):2224-30. doi: 10.1111/ajt.13893.

10.

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

Weiner LM, Fridkin SK, Aponte-Torres Z, Avery L, Coffin N, Dudeck MA, Edwards JR, Jernigan JA, Konnor R, Soe MM, Peterson K, McDonald LC.

MMWR Morb Mortal Wkly Rep. 2016 Mar 11;65(9):235-41. doi: 10.15585/mmwr.mm6509e1.

11.

Probabilistic Measurement of Central Line-Associated Bloodstream Infections.

Hota B, Malpiedi P, Fridkin SK, Martin J, Trick W.

Infect Control Hosp Epidemiol. 2016 Feb;37(2):149-55. doi: 10.1017/ice.2015.255. Epub 2015 Dec 14.

PMID:
26654731
12.

Evaluating the Use of the Case Mix Index for Risk Adjustment of Healthcare-Associated Infection Data: An Illustration using Clostridium difficile Infection Data from the National Healthcare Safety Network.

Thompson ND, Edwards JR, Dudeck MA, Fridkin SK, Magill SS.

Infect Control Hosp Epidemiol. 2016 Jan;37(1):19-25. doi: 10.1017/ice.2015.252. Epub 2015 Oct 21.

13.

Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Recent Discharge From an Acute-Care Hospitalization, 2011-2013.

Epstein L, Mu Y, Belflower R, Scott J, Ray S, Dumyati G, Felsen C, Petit S, Yousey-Hindes K, Nadle J, Pasutti L, Lynfield R, Warnke L, Schaffner W, Leib K, Kallen AJ, Fridkin SK, Lessa FC.

Clin Infect Dis. 2016 Jan 1;62(1):45-52. doi: 10.1093/cid/civ777. Epub 2015 Sep 3.

14.

Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance.

Fridkin SK, Cleveland AA, See I, Lynfield R.

Emerg Infect Dis. 2015 Sep;21(9):1578-81. doi: 10.3201/eid2109.150512.

15.

Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States.

Magill SS, Dumyati G, Ray SM, Fridkin SK.

Emerg Infect Dis. 2015 Sep;21(9):1537-42. doi: 10.3201/eid2109.150508.

16.

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations.

Lessa FC, Mu Y, Winston LG, Dumyati GK, Farley MM, Beldavs ZG, Kast K, Holzbauer SM, Meek JI, Cohen J, McDonald LC, Fridkin SK.

Open Forum Infect Dis. 2014 Jul 28;1(2):ofu048. doi: 10.1093/ofid/ofu048. eCollection 2014 Sep.

17.

Burden of Clostridium difficile infection in the United States.

Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC.

N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.

18.

Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011.

Soe MM, Edwards JR, Sievert DM, Ricks PM, Magill SS, Fridkin SK.

Infect Control Hosp Epidemiol. 2015 Jan;36(1):54-64. doi: 10.1017/ice.2014.11.

19.

Multicenter evaluation of computer automated versus traditional surveillance of hospital-acquired bloodstream infections.

Lin MY, Woeltje KF, Khan YM, Hota B, Doherty JA, Borlawsky TB, Stevenson KB, Fridkin SK, Weinstein RA, Trick WE; Centers for Disease Control and Prevention Epicenter Program.

Infect Control Hosp Epidemiol. 2014 Dec;35(12):1483-90. doi: 10.1086/678602. Epub 2014 Nov 7.

PMID:
25419770
20.

Prevalence of antimicrobial use in US acute care hospitals, May-September 2011.

Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, Lynfield R, Nadle J, Neuhauser MM, Ray SM, Richards K, Rodriguez R, Thompson DL, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team.

JAMA. 2014 Oct 8;312(14):1438-46. doi: 10.1001/jama.2014.12923.

PMID:
25291579
21.

Survey of health care-associated infections.

Magill SS, Edwards JR, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team.

N Engl J Med. 2014 Jun 26;370(26):2542-3. doi: 10.1056/NEJMc1405194. No abstract available.

PMID:
24963580
22.

Multistate point-prevalence survey of health care-associated infections.

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team.

N Engl J Med. 2014 Mar 27;370(13):1198-208. doi: 10.1056/NEJMoa1306801.

23.

Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States.

Fridkin SK, Srinivasan A.

Clin Infect Dis. 2014 Feb;58(3):401-6. doi: 10.1093/cid/cit710. Epub 2013 Oct 25. Review.

24.

Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990-2010.

Fagan RP, Edwards JR, Park BJ, Fridkin SK, Magill SS.

Infect Control Hosp Epidemiol. 2013 Sep;34(9):893-9. doi: 10.1086/671724. Epub 2013 Jul 16.

25.

National estimates of central line-associated bloodstream infections in critical care patients.

Wise ME, Scott RD 2nd, Baggs JM, Edwards JR, Ellingson KD, Fridkin SK, McDonald LC, Jernigan JA.

Infect Control Hosp Epidemiol. 2013 Jun;34(6):547-54. doi: 10.1086/670629. Epub 2013 Apr 18.

26.

Community-onset invasive methicillin-resistant Staphylococcus aureus infections following hospital discharge.

Duffy J, Dumyati G, Bulens S, Namburi S, Gellert A, Fridkin SK, Lessa FC.

Am J Infect Control. 2013 Sep;41(9):782-6. doi: 10.1016/j.ajic.2012.10.020. Epub 2013 Feb 5.

PMID:
23394888
27.

Effect of nonpayment for preventable infections in U.S. hospitals.

Lee GM, Kleinman K, Soumerai SB, Tse A, Cole D, Fridkin SK, Horan T, Platt R, Gay C, Kassler W, Goldmann DA, Jernigan J, Jha AK.

N Engl J Med. 2012 Oct 11;367(15):1428-37. doi: 10.1056/NEJMsa1202419.

28.

Device-associated infection rates, device utilization, and antimicrobial resistance in long-term acute care hospitals reporting to the National Healthcare Safety Network, 2010.

Chitnis AS, Edwards JR, Ricks PM, Sievert DM, Fridkin SK, Gould CV.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):993-1000. doi: 10.1086/667745. Epub 2012 Aug 23.

PMID:
22961018
29.

Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009.

Chitnis AS, Magill SS, Edwards JR, Chiller TM, Fridkin SK, Lessa FC.

Pediatrics. 2012 Jul;130(1):e46-52. doi: 10.1542/peds.2011-3620. Epub 2012 Jun 18.

PMID:
22711720
30.

Investigating systematic misclassification of central line-associated bloodstream infection (CLABSI) to secondary bloodstream infection during health care-associated infection reporting.

Thompson ND, Yeh LL, Magill SS, Ostroff SM, Fridkin SK.

Am J Med Qual. 2013 Jan-Feb;28(1):56-9. doi: 10.1177/1062860612442565. Epub 2012 Jun 7.

PMID:
22679125
31.

Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.

Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, DeStefano F, Fridkin SK, Vellozzi C, Morgan OW.

Am J Epidemiol. 2012 Jun 1;175(11):1110-9. doi: 10.1093/aje/kws196. Epub 2012 May 11.

32.

Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections.

Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, DeVries AS, Schaffner W, Nadle J, Gershman K, Fridkin SK; Active Bacterial Core surveillance (ABCs); MRSA Investigators of the Emerging Infections Program.

Clin Infect Dis. 2012 Jul;55(2):232-41. doi: 10.1093/cid/cis408. Epub 2012 Apr 20.

PMID:
22523264
33.

Improved risk adjustment in public reporting: coronary artery bypass graft surgical site infections.

BerrĂ­os-Torres SI, Mu Y, Edwards JR, Horan TC, Fridkin SK.

Infect Control Hosp Epidemiol. 2012 May;33(5):463-9. doi: 10.1086/665313. Epub 2012 Mar 20.

PMID:
22476272
34.

Improving surveillance definitions for ventilator-associated pneumonia in an era of public reporting and performance measurement.

Magill SS, Fridkin SK.

Clin Infect Dis. 2012 Feb 1;54(3):378-80. doi: 10.1093/cid/cir833. No abstract available.

PMID:
22247301
35.

Network approach for prevention of healthcare-associated infections.

Horan TC, Arnold KE, Rebmann CA, Fridkin SK.

Infect Control Hosp Epidemiol. 2011 Nov;32(11):1143-4. doi: 10.1086/662588. No abstract available.

PMID:
22011548
36.

Improving risk-adjusted measures of surgical site infection for the national healthcare safety network.

Mu Y, Edwards JR, Horan TC, Berrios-Torres SI, Fridkin SK.

Infect Control Hosp Epidemiol. 2011 Oct;32(10):970-86. doi: 10.1086/662016. Epub 2011 Sep 1.

PMID:
21931247
37.

Trends in catheter-associated urinary tract infections in adult intensive care units-United States, 1990-2007.

Burton DC, Edwards JR, Srinivasan A, Fridkin SK, Gould CV.

Infect Control Hosp Epidemiol. 2011 Aug;32(8):748-56. doi: 10.1086/660872.

PMID:
21768757
38.

Meaningful measure of performance: a foundation built on valid, reproducible findings from surveillance of health care-associated infections.

Fridkin SK, Olmsted RN.

Am J Infect Control. 2011 Mar;39(2):87-90. doi: 10.1016/j.ajic.2011.01.002. No abstract available.

PMID:
21356430
39.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF.

Clin Infect Dis. 2011 Feb 1;52(3):285-92. doi: 10.1093/cid/cir034.

PMID:
21217178
40.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF; Infectious Diseases Society of America.

Clin Infect Dis. 2011 Feb 1;52(3):e18-55. doi: 10.1093/cid/ciq146. Epub 2011 Jan 4. Erratum in: Clin Infect Dis. 2011 Aug 1;53(3):319.

PMID:
21208910
41.

Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006-2007.

Lessa FC, Mu Y, Davies J, Murray M, Lillie M, Pearson A, Fridkin SK; Emerging Infections Program/Active Bacterial Core surveillance MRSA Investigators and the Health Protection Agency Team.

Clin Infect Dis. 2010 Oct 15;51(8):925-8. doi: 10.1086/656414.

PMID:
20815734
42.

Health care-associated invasive MRSA infections, 2005-2008.

Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Patel PR, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program.

JAMA. 2010 Aug 11;304(6):641-8. doi: 10.1001/jama.2010.1115.

PMID:
20699455
43.

Risk factors for community-associated Staphylococcus aureus infections: results from parallel studies including methicillin-resistant and methicillin-sensitive S. aureus compared to uninfected controls.

Como-Sabetti KJ, Harriman KH, Fridkin SK, Jawahir SL, Lynfield R.

Epidemiol Infect. 2011 Mar;139(3):419-29. doi: 10.1017/S0950268810001111. Epub 2010 Jun 1.

PMID:
20513251
44.

Outcomes among inmates treated for coccidioidomycosis at a correctional institution during a community outbreak, Kern County, California, 2004.

Burwell LA, Park BJ, Wannemuehler KA, Kendig N, Pelton J, Chaput E, Jinadu BA, Emery K, Chavez G, Fridkin SK.

Clin Infect Dis. 2009 Dec 1;49(11):e113-9. doi: 10.1086/648119.

PMID:
19886797
45.

Contaminated product water as the source of Phialemonium curvatum bloodstream infection among patients undergoing hemodialysis.

Rao CY, Pachucki C, Cali S, Santhiraj M, Krankoski KL, Noble-Wang JA, Leehey D, Popli S, Brandt ME, Lindsley MD, Fridkin SK, Arduino MJ.

Infect Control Hosp Epidemiol. 2009 Sep;30(9):840-7. doi: 10.1086/605324.

PMID:
19614543
46.

Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States.

Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Fridkin SK; Active Bacterial Core surveillance MRSA Investigators.

Vaccine. 2009 Aug 13;27(37):5061-8. doi: 10.1016/j.vaccine.2009.06.055. Epub 2009 Jul 2.

PMID:
19576943
47.

Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004.

Lessa FC, Edwards JR, Fridkin SK, Tenover FC, Horan TC, Gorwitz RJ.

Pediatr Infect Dis J. 2009 Jul;28(7):577-81. doi: 10.1097/INF.0b013e31819988bf.

PMID:
19478687
48.

Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis.

Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, Heltzel D, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Mu Y, Fridkin SK; Active Bacterial Core surveillance MRSA Investigators.

J Clin Microbiol. 2009 May;47(5):1344-51. doi: 10.1128/JCM.02264-08. Epub 2009 Mar 25.

49.

Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007.

Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK.

JAMA. 2009 Feb 18;301(7):727-36. doi: 10.1001/jama.2009.153.

PMID:
19224749
50.

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.

Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities.

Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011. doi: 10.1086/591861. Erratum in: Infect Control Hosp Epidemiol. 2009 Jan;30(1):107.

PMID:
18947320

Supplemental Content

Loading ...
Support Center